Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,103 | 155 | 85.2% |
| Travel and Lodging | $537.26 | 3 | 14.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,038 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $628.64 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $448.35 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $298.17 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $252.46 | 13 | $0 (2024) |
| PFIZER INC. | $232.73 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $207.91 | 9 | $0 (2024) |
| Amgen Inc. | $158.55 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $144.28 | 6 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $108.80 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,678 | 71 | Abbott Laboratories ($926.38) |
| 2023 | $1,468 | 68 | Novartis Pharmaceuticals Corporation ($452.51) |
| 2022 | $495.13 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($133.99) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Heart Failure | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.86 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/13/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Heart Failure | ||||||
| 09/02/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Obesity | ||||||
| 07/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.95 | General |
| Category: Cardiovascular | ||||||
| 07/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.66 | General |
| Category: Cardiovascular | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: DIABETES | ||||||
| 06/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.43 | General |
| Category: Cardiovascular | ||||||
| 06/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.86 | General |
| Category: Cardiovascular | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.88 | General |
| Category: Cardiovascular | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.33 | General |
| Category: Cardiovascular | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.11 | General |
| Category: Cardiovascular | ||||||
| 06/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.83 | General |
| Category: Cardiovascular | ||||||
| 05/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.99 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 528 | 905 | $76,925 | $21,992 |
| 2022 | 4 | 512 | 1,040 | $80,478 | $21,319 |
| 2021 | 2 | 83 | 116 | $26,080 | $6,235 |
| 2020 | 1 | 46 | 77 | $14,938 | $4,067 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 228 | $41,650 | $13,892 | 33.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 27 | $6,948 | $2,604 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 53 | $6,445 | $2,161 | 33.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 60 | 301 | $11,137 | $1,811 | 16.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 220 | 296 | $10,745 | $1,525 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 197 | 254 | $49,026 | $15,207 | 31.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 69 | 476 | $17,921 | $3,221 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 32 | $3,805 | $1,466 | 38.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 215 | 278 | $9,726 | $1,426 | 14.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 93 | $19,065 | $4,570 | 24.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 23 | 23 | $7,015 | $1,665 | 23.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 46 | 77 | $14,938 | $4,067 | 27.2% |
About Karisa Tobon
Karisa Tobon is a Cardiovascular Disease healthcare provider based in Torrington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2020. The National Provider Identifier (NPI) number assigned to this provider is 1376165100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Karisa Tobon has received a total of $3,641 in payments from pharmaceutical and medical device companies, with $1,678 received in 2024. These payments were reported across 158 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,103).
As a Medicare-enrolled provider, Tobon has provided services to 1,169 Medicare beneficiaries, totaling 2,138 services with total Medicare billing of $53,613. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Physician Assistant
- Location Torrington, CT
- Active Since 05/14/2020
- Last Updated 03/13/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1376165100
Products in Payments
- CARDIOMEMS (Device) $997.44
- LEQVIO (Drug) $542.54
- JARDIANCE (Drug) $448.35
- XARELTO (Drug) $252.46
- ELIQUIS (Drug) $213.99
- FARXIGA (Drug) $190.02
- CAMZYOS (Drug) $185.91
- Repatha (Biological) $158.55
- VERQUVO (Drug) $144.28
- VYNDAQEL (Drug) $131.00
- Arcalyst (Drug) $108.80
- ENTRESTO (Drug) $86.10
- Kerendia (Drug) $32.92
- LifeVest (Device) $25.86
- JOT DX (Device) $22.74
- Wegovy (Drug) $22.24
- Inpefa (Drug) $22.21
- ONPATTRO (Drug) $19.38
- MERLIN@HOME (Device) $17.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Torrington
Robert Kahan, Md, MD
Cardiovascular Disease — Payments: $9,003
Michael Fowler, Md, MD
Cardiovascular Disease — Payments: $8,732
Carrie Wolfberg, Md, MD
Cardiovascular Disease — Payments: $4,499
Joseph Abreu, Md, MD
Cardiovascular Disease — Payments: $2,650
Dr. Liran Blum, Md, MD
Cardiovascular Disease — Payments: $2,146